Drug-labels.com

Cefuroxime for Injection, USP (Fresenius Kabi Canada, 7.5 G): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
7.5 g
Active ingredient:
ATC code:
Similar drugs:

Source: Health Canada – Drug Product Database (DPD) and product monographs · About this document

Patient Medication Information: uses, side effects, how to take - Cefuroxime for Injection, USP (Fresenius Kabi Canada, 7.5 G)

What is Cefuroxime for Injection, USP used for?

Cefuroxime for Injection, USP is used for the treatment of infections caused by certain bacteria in many different parts of the body.

Cefuroxime for Injection, USP can also be used to prevent infections, before and after surgery.

Antibacterial drugs like Cefuroxime for Injection, USP treat only bacterial infections. They do not treat viral infections.

How does Cefuroxime for Injection, USP work?

Cefuroxime for Injection, USP is an antibiotic, which belongs to a class of drugs called cephalosporins. Cefuroxime for Injection, USP works by killing bacteria that cause infections in the body.

What are the ingredients in Cefuroxime for Injection, USP?

Medicinal ingredients: cefuroxime sodium

Non-medicinal ingredients: None

Cefuroxime for Injection, USP comes in the following dosage forms:

Sterile powder for injection: 750 mg / 15 mL, 1.5 g / 50 mL, 7.5 g / 100 mL

Do not use Cefuroxime for Injection, USP if:

You are allergic to cefuroxime or to cephalosporin antibiotics.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take Cefuroxime for Injection, USP. Talk about any health conditions or problems you may have, including if you:

  • are allergic to or react badly to penicillins or other antibiotics.
  • have kidney problems, as your healthcare professional may reduce your dose.
  • have a history of bowel disease, particularly colitis.
  • are taking other antibiotics called aminoglycosides, such as streptomycin, neomycin, gentamicin and tobramycin.
  • are taking “water pills” or diuretics used to lower high blood pressure, such as furosemide and ethacrynic acid.
  • are having a urine test for sugar as Cefuroxime for Injection, USP can affect the results.

  • are pregnant or planning to become pregnant.

  • are breastfeeding or planning to breastfeed. Cefuroxime for Injection, USP is passed into breast milk. Discuss whether you should breastfeed while taking Cefuroxime for Injection, USP with your health care professional.

Other warnings you should know about:

Driving and using machines: Cefuroxime for Injection, USP can cause dizziness. Do not drive or operate machinery if you are feeling dizzy.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with Cefuroxime for Injection, USP:

  • Diuretics or “water pills” used to lower high blood pressure, such as furosemide and ethacrynic acid

How to take Cefuroxime for Injection, USP:

  • Cefuroxime for Injection, USP will be given to you by a healthcare professional who will inject it into a vein.
  • Although you may feel better early in treatment, Cefuroxime for Injection, USP should be used exactly as directed.
  • Misuse or overuse of Cefuroxime for Injection, USP could lead to the growth of bacteria that will not be killed by Cefuroxime for Injection, USP (resistance). This means that Cefuroxime for Injection, USP may not work for you in the future.
  • Do not share your medicine.

Usual dose:

Your healthcare professional will decide how much, how often and for how long you will receive Cefuroxime for Injection, USP.

Overdose:

If you think you have been given too much Cefuroxime for Injection, USP, contact your healthcare professional, hospital emergency department or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you miss an appointment to receive an injection of Cefuroxime for Injection, USP contact your healthcare professional as soon as possible.

What are possible side effects from using Cefuroxime for Injection, USP?

These are not all the possible side effects you may feel when taking Cefuroxime for Injection, USP. If you experience any side effects not listed here, contact your healthcare professional.

Side effects may include:

  • Drowsiness, feeling faint
  • Loose stool
  • Sweating
  • Pain and stiffness at the injection site

Cefuroxime for Injection, USP can cause abnormal blood test results. Your healthcare professional will decide when to perform blood tests and interpret the results. Also, tell any healthcare professionals you see before having blood work that you are taking Cefuroxime for Injection, USP as it may affect your results.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help

Only if

severe

In all cases
RARE
  • Yeast infection of the skin: redness, burning and itching in the skin
  • folds, commonly in the groin, under the breasts and in the arm pit
  • •
✓

Pseudomembranous colitis: watery, bloody diarrhea, mucus in the

stool, abdominal cramps and pain, fever

✓
VERY RARE

Allergic Reaction: wheeziness and tightness of chest, swelling of

eyelids, face or lips, or develop skin lumps or hives, or a skin rash (red

spots), high fever.

✓

Skin Reaction: skin rash, which may blister, and looks like small targets

(central dark spots surrounded by a paler area, with a dark ring around

the edge), widespread rash with blisters and skin peeling on much of the

body, particularly around the mouth, nose, eyes and genitals.

✓
Heart palpitations: fast, slow or irregular heartbeat✓

Kidney problems: decreased urination, nausea, vomiting, swelling of

extremities, fatigue

✓

Liver problems: yellowing of the skin or eyes, dark urine, abdominal

pain, nausea, vomiting, loss of appetite

✓
Anemia: fatigue, loss of energy, weakness, shortness of breath✓

Low levels of white blood cells: infection, fatigue, fever, aches, pain,

flu-like symptoms

✓

Phlebitis: swelling of a vein near the injection site, with pain,

tenderness, redness

✓
UNKNOWN

Severe Cutaneous Adverse Reactions (SCAR) (severe skin reactions

that may also affect other organs):

  • Skin peeling, scaling, or blistering (with or without pus) which may also affect your eyes, mouth, nose or genitals, itching, severe rash, bumps under the skin, skin pain, skin color changes (redness, yellowing, purplish)
  • Swelling and redness of eyes or face
  • Flu-like feeling, fever, chills, body aches, swollen glands, cough
  • Shortness of breath, chest pain or discomfort
✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Cefuroxime for Injection, USP will be stored by your healthcare professional at room temperature (15 °C and 30 °C) in a dry place, protected from light.
  • Keep out of reach and sight of children.

If you want more information about Cefuroxime for Injection, USP:

  • Talk to your healthcare professional

  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (http://www.canada.ca/en/health-canada.html); or by calling Fresenius Kabi Canada Ltd., at

    1-877-821-7724.

Fresenius Kabi Canada Ltd.

165 Galaxy Blvd, Suite 100

Toronto, ON M9W 0C8

Last Revised: April 17, 2020

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02241640

Revision date stated in the text: April 17, 2020

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Cefuroxime for Injection, USP (Fresenius Kabi Canada, 7.5 G)

Rx or OTC
Prescription (Rx)?
DIN 02241640
Schedule(s) PRESCRIPTION
Active ingredient(s) Cefuroxime (cefuroxime sodium) 7.5 G
Dosage form(s) Powder For Solution
Route(s) of administration Intravenous
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01D Other beta-lactam antibacterials
        1. J01DC Second-generation cephalosporins
          1. J01DC02 Cefuroxime
Company FRESENIUS KABI CANADA LTD
Current status Cancelled Post Market
Current status date February 28, 2024

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.